FIELD: medicine.
SUBSTANCE: hydrophilic therapeutic agent is specified in a group consisting of albuterol, bendamustine, captopril, carboplatin, ciprofloxacin, gemcitabine, ibandronate, lamivudine, metformin, niacin, oxycodone, ranitidine and sumatriptan. The composition also contains a solvent, a surfactant and a hydrophilic carrier. The above hydrophilic carrier is compatible to the therapeutic agent solution and the surfactant.
EFFECT: good stability and bioavailability compatible to that of injection formulations when administered orally.
21 cl, 2 dwg, 13 tbl, 4 ex
Authors
Dates
2014-11-10—Published
2010-04-27—Filed